TCT-448 Impact of Clinical Indication / Risk Strata on Outcomes in Patients Supported with Impella Microaxial Heart Pumps

Eisha Wali(Chicago Department of Public Health), Sandeep Nathan(University of Chicago), Taishi Hirai(University of Chicago), Roderick Tung(Harvard University), John E. Blair, P. Larsen(University of Chicago), Atman P. Shah(University of Chicago), Linda Lee(University of Chicago), Joseph Venturini(University of Chicago), Jonathan Paul(University of Chicago), Margaret Lee(University of Chicago)
Journal of the American College of Cardiology
September 1, 2018
10.1016/j.jacc.2018.08.1616
Cited by 0

Related Papers

Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association
|Circulation|2019|1.3k
The N-terminal Pro-BNP Investigation of Dyspnea in the Emergency department (PRIDE) study
|The American Journal of Cardiology|2005|1.2k
Freedom from recurrent ventricular tachycardia after catheter ablation is associated with improved survival in patients with structural heart disease: An International VT Ablation Center Collaborative Group study
|Heart Rhythm|2015|497
Multicenter Outcomes for Catheter Ablation of Idiopathic Premature Ventricular Complexes
|JACC. Clinical electrophysiology|2015|382
Criteria for Defining Stages of Cardiogenic Shock Severity
|Journal of the American College of Cardiology|2022|283